Albumin did not diffuse into the dialysate because the molecule is too large to pass through the pores of a dialysis membrane. Human serum albumin has a molecular weight of roughly 66,700 daltons, while standard dialysis membranes only allow molecules up to about 10,000 to 15,000 daltons to cross. This size mismatch is the primary reason albumin stays put, but several other physical and chemical factors reinforce that barrier.
Albumin Is Too Large for the Membrane Pores
Dialysis works by separating molecules based on size. A semipermeable membrane acts like a filter with microscopic pores: small molecules such as salts, urea, and glucose slip through easily, while larger molecules cannot fit. Albumin, at 66,700 daltons, is roughly four to six times heavier than the upper limit of what a standard dialysis membrane permits. Even high-flux membranes, which are designed to clear slightly larger waste products, cap out at removing molecules in the 10,000 to 15,000 dalton range. Albumin simply cannot squeeze through openings that small.
This is why dialysis membranes are described as “semipermeable.” They are selective. Water and dissolved small solutes move down their concentration gradients from blood into the dialysate, but proteins like albumin are physically blocked. If you ran a lab experiment using dialysis tubing and found no albumin in your dialysate sample, this size exclusion is the explanation your instructor is looking for.
Electrical Charge Adds a Second Barrier
Size alone accounts for most of the retention, but charge plays a supporting role. At normal blood pH (7.4), albumin carries a strong negative electrical charge of about -15. Many dialysis membranes also carry a slight negative surface charge. Because like charges repel, albumin molecules are pushed away from the membrane surface even before they reach the pores. This electrostatic repulsion makes it even less likely that albumin would sneak through a pore that might otherwise be borderline large enough.
A Protein Layer Forms During Dialysis
Once blood contacts the membrane, plasma proteins quickly adsorb onto its surface, forming what is sometimes called a “secondary membrane” or fouling layer. This protein coating effectively shrinks the functional pore size further and reduces the passage of solutes across the membrane. Studies on dialyzer fouling consistently show that solute clearance drops once this layer builds up. For a molecule already far too large to cross, this fouling layer is one more obstacle, but it matters more for mid-sized molecules that sit closer to the membrane’s cutoff threshold.
How Retention Is Measured Clinically
Engineers quantify how well a membrane blocks a given molecule using something called a sieving coefficient. A sieving coefficient of 1 means a molecule passes through freely; a coefficient of 0 means it is completely blocked. For albumin on commercial dialyzers, the sieving coefficient is extremely close to zero. In standardized testing with human plasma, values ranged from 0.04% to 0.27% across several widely used dialyzer models. In practical terms, that means less than three-tenths of one percent of the albumin in blood makes it across, and most of that occurs through convective drag in certain treatment modes rather than true diffusion.
Even in more aggressive treatments like hemodiafiltration, where fluid is actively pushed through the membrane, albumin loss typically stays between 1 and 3 grams per session. That may sound like a lot, but the body contains roughly 300 to 500 grams of albumin total, and clinical guidelines suggest losses under 4 grams per session pose little risk to patients.
Why Keeping Albumin Out of the Dialysate Matters
Albumin is the most abundant protein in blood plasma, making up about 50% of all circulating serum proteins. One of its critical jobs is maintaining oncotic pressure, the force that keeps fluid inside blood vessels rather than leaking into surrounding tissues. If albumin were freely lost into the dialysate, oncotic pressure would drop and fluid would shift out of the bloodstream, leading to swelling (edema), dangerously low blood pressure, and other complications. Albumin also transports hormones, fatty acids, and medications through the bloodstream, so losing it would impair drug delivery and metabolism.
This is precisely why dialysis membranes are engineered with a molecular weight cutoff well below albumin’s size. The goal is to clear small waste products like urea, creatinine, and excess electrolytes while keeping essential proteins in the blood where they belong.
Newer Membranes Push the Boundary
Some newer membrane designs, called medium cut-off (MCO) and high cut-off (HCO) membranes, intentionally raise the pore size to remove slightly larger waste molecules that standard membranes miss. These “protein-leaking” membranes improve clearance of mid-sized toxins but introduce the risk of pulling albumin across as well. Clinical protocols using these membranes require careful adjustments, such as diluting the blood before it reaches the filter, to keep albumin losses within safe limits. The fact that engineers must actively work to prevent albumin leakage with these larger-pore membranes underscores just how effectively standard membranes block it by default.
Putting It All Together
Three factors work in concert to keep albumin on the blood side of a dialysis membrane. First, the molecule is far too large for the membrane’s pores. Second, its strong negative charge is repelled by the membrane surface. Third, a layer of adsorbed proteins further tightens the barrier during treatment. Of these, size is by far the dominant factor. If you are answering a physiology or biology lab question, the core answer is straightforward: albumin’s molecular weight of roughly 66,700 daltons vastly exceeds the membrane’s cutoff of 10,000 to 15,000 daltons, so it physically cannot pass through.